← Back

Wire · opportunities

PFAS in Medical Devices: What You Need to Know

Published

1 September 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at fda.gov

Verified

Fusion42 · 1 September 2026 · Fusion42 review

The FDA clarified that fluoropolymers, a subset of PFAS used in medical devices, differ chemically from harmful PFAS linked to environmental and health concerns. They concluded that fluoropolymers remain safe and essential for critical medical devices like catheters and cardiovascular implants and do not warrant usage restrictions.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ The Wire takeaway

You face clarity from the FDA that fluoropolymers in medical devices remain approved without restriction. This reduces regulatory uncertainty for Medtech developers relying on these materials, letting you continue work without redesigning critical device components.

Coverage

1 source · 1 Sep 2026

Related on Wire

Topics

Medtechpfasmedical-devicesregulatory-updatefluoropolymersfda-safety